×
About 3,975 results

ALLMedicine™ Thrombolytic Therapy Center

Research & Reviews  1,186 results

Optimal management, prevalence, and clinical behavior of saddle pulmonary embolism: A s...
https://doi.org/10.1016/j.thromres.2022.07.013
Thrombosis Research; Ata F, Ibrahim WH et. al.

Aug 5th, 2022 - The central location, size, and instability of saddle pulmonary embolism (SPE) have raised significant concerns regarding its clinical, hemodynamic effects as well as optimal management. Pulmonary embolism (PE) guidelines barely address such conce...

Antiplatelet vs R-tPA for Acute Mild Ischemic Stroke
https://clinicaltrials.gov/ct2/show/NCT03661411

Aug 3rd, 2022 - Acute ischemic stroke (AIS) is one of common diseases with significant morbidity, mortality and disability. A wide array of studies confirms that intravenous thrombolytic therapy with alteplase can effectively improve the functional prognosis in a...

Optimal Post Tpa-Iv Monitoring in Ischemic Stroke
https://clinicaltrials.gov/ct2/show/NCT03734640

Aug 3rd, 2022 - Research question: Patients receiving thrombolytic therapy (tissue plasminogen activator [tPA]) for acute ischaemic stroke (AIS), have been monitored with a high intensity schedule of vital signs and neurologic assessments, which often requires 1:...

Short-term prognostic value of clinical data in hospitalized patients with intermediate...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9331586
BMC Cardiovascular Disorders; Liu J, Liu Y et. al.

Jul 29th, 2022 - Intermediate-risk acute pulmonary embolism (APE) patients are usually defined as hemodynamically stable, comprehending a great therapeutic dilemma. Although anticoagulation therapy is sufficient for most intermediate-risk APE patients, some patien...

Impact of COVID-19 pandemic on STEMI thrombolysis and Emergency Department's performanc...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9287574
The American Journal of Emergency Medicine; Koh HP, Md Redzuan A et. al.

Jul 26th, 2022 - Some guidelines had recommended "thrombolysis first" in ST-elevated myocardial infarction (STEMI) during the Coronavirus Disease 2019 (COVID-19) outbreak. The impact of COVID-19 solely on STEMI thrombolysis is lacking as most studies reported outc...

see more →

Guidelines  15 results

Management of simple and retained hemothorax: A practice management guideline from the ...
https://doi.org/10.1016/j.amjsurg.2020.11.032
American Journal of Surgery; Patel NJ, Dultz L et. al.

Jan 26th, 2021 - Traumatic hemothorax poses diagnostic and therapeutic challenges both acutely and chronically. A working group of the Eastern Association for the Surgery of Trauma convened to formulate a practice management guideline for traumatic hemothorax. We ...

American Society of Hematology 2020 guidelines for management of venous thromboembolism...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556153
Blood Advances; Ortel TL, Neumann I et. al.

Oct 3rd, 2020 - Venous thromboembolism (VTE), which includes deep vein thrombosis (DVT) and pulmonary embolism (PE), occurs in ∼1 to 2 individuals per 1000 each year, corresponding to ∼300 000 to 600 000 events in the United States annually. These evidence-based ...

Antithrombotic Therapy for Atrial Fibrillation: CHEST Guideline and Expert Panel Report.
https://doi.org/10.1016/j.chest.2018.07.040
Chest Lip GYH, Banerjee A et. al.

Aug 26th, 2018 - The risk of stroke is heterogeneous across different groups of patients with atrial fibrillation (AF), being dependent on the presence of various stroke risk factors. We provide recommendations for antithrombotic treatment based on net clinical be...

Regional Anesthesia in the Patient Receiving Antithrombotic or Thrombolytic Therapy: Am...
https://doi.org/10.1097/AAP.0000000000000763
Regional Anesthesia and Pain Medicine; Horlocker TT, Vandermeuelen E et. al.

Mar 22nd, 2018 - Regional Anesthesia in the Patient Receiving Antithrombotic or Thrombolytic Therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (Fourth Edition).|2018|Horlocker TT,Vandermeuelen E,Kopp SL,Gogarten W,Leffert...

Consensus statement on the use of intravenous recombinant tissue plasminogen activator ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6493470
CNS Neuroscience & Therapeutics; Xu AD, Wang YJ et. al.

May 29th, 2013 - The last update of the consensus statement on intravenous recombinant tissue plasminogen activator (IV rt-PA) for acute ischemic stroke (AIS) by the Chinese Stroke Therapy Expert Panel was published in 2006. Great progress has been made since then...

see more →

Drugs  13 results see all →

Clinicaltrials.gov  140 results

Antiplatelet vs R-tPA for Acute Mild Ischemic Stroke
https://clinicaltrials.gov/ct2/show/NCT03661411

Aug 3rd, 2022 - Acute ischemic stroke (AIS) is one of common diseases with significant morbidity, mortality and disability. A wide array of studies confirms that intravenous thrombolytic therapy with alteplase can effectively improve the functional prognosis in a...

Optimal Post Tpa-Iv Monitoring in Ischemic Stroke
https://clinicaltrials.gov/ct2/show/NCT03734640

Aug 3rd, 2022 - Research question: Patients receiving thrombolytic therapy (tissue plasminogen activator [tPA]) for acute ischaemic stroke (AIS), have been monitored with a high intensity schedule of vital signs and neurologic assessments, which often requires 1:...

Efficacy and Safety of an Early Phase Single-bolus r-SAK for Acute Myocardial Infarction
https://clinicaltrials.gov/ct2/show/NCT05410925

Jul 13th, 2022 - Acute myocardial infarction (AMI) is a serious and critical disease that causes acute coronary artery stenosis, spasm or occlusion due to the rupture or erosion of coronary artery plaque, resulting in myocardial ischemia and necrosis. Myocardial i...

EXtending the Time Window for Thrombolysis in Posterior Circulation Stroke Without Early CT Signs
https://clinicaltrials.gov/ct2/show/NCT05429476

Jul 1st, 2022 - Posterior circulation stroke accounts for 20-25% of all ischemic strokes, with an annual adjusted incidence of 18 per 100,000 person-years. Compared with anterior circulation stroke, posterior circulation stroke is less studied and has poor neurol...

Effectiveness of Butylphthalide on Dynamic Cerebral Autoregulation in Patients With Acute Ischemic Stroke.
https://clinicaltrials.gov/ct2/show/NCT03413202

Jun 30th, 2022 - Cerebral stroke, the first cause of death in China, seriously affects the health and living of people. Its high incidence, disability, mortality and recurrence rate give a heavy burden on the family, society and country. According to TOAST classif...

see more →

News  235 results

'Case Closed:' Bridging Thrombolysis Remains 'Gold Standard' in Stroke Thrombectomy 
https://www.medscape.com/viewarticle/977223

Jul 14th, 2022 - Two new non-inferiority trials address the controversial question of whether thrombolytic therapy can be omitted for acute ischemic stroke in patients undergoing endovascular thrombectomy for large-vessel occlusion. Both trials show better outcome...

AHA/ASA Statement on Acute Stroke Care for Adults With Disability or Dementia
https://www.medscape.com/viewarticle/971115

Mar 29th, 2022 - Adults with pre-existing dementia or disability who suffer acute ischemic stroke can benefit from endovascular therapy (EVT) or thrombolysis, the American Heart Association (AHA)/American Stroke Association (ASA) says in a scientific statement rel...

Shorter Course of Anticoagulant Therapy Adequate for Provoked VTE in Children
https://www.medscape.com/viewarticle/966398

Jan 12th, 2022 - NEW YORK (Reuters Health) - For children with acute provoked venous thromboembolism (VTE), six weeks of anticoagulant therapy is as effective as a three-month course of anticoagulant therapy, results of a new clinical trial suggest. "When treatmen...

Refined heart rate cutoffs may improve prognostic value of acute PE scoring systems
https://www.mdedge.com/chestphysician/article/246415/venous-thromboembolism/refined-heart-rate-cutoffs-may-improve
Andrew D. Bowser

Sep 21st, 2021 - In patients with acute pulmonary embolism, using cutoff values other than 110 beats per minute might improve the prognostic value of heart rate at admission, a recent observational study suggests. Courtesy of Mercy Medical Center Dr.

Cutaneous Cholesterol Embolization to the Lower Trunk: An Underrecognized Presentation
https://www.mdedge.com/dermatology/article/237479/dermatopathology/cutaneous-cholesterol-embolization-lower-trunk
Nooshin K. Brinster, MD, Mark Levy, MD et. al.

Mar 22nd, 2021 - To the Editor: A 65-year-old man with severe atherosclerotic disease developed multiple painful eschars on the lower abdomen, thighs, sacrum, and perineum. He initially presented with myocardial ischemia and claudication and underwent 3 cardiac ca.

see more →

Patient Education  1 results see all →